Literature DB >> 21502540

Conducting cancer control and survivorship research via cooperative groups: a report from the American Society of Preventive Oncology.

Oxana Palesh1, Wendy Demark-Wahnefried, Karen Mustian, Lori Minasian, Julia Rowland, Lisa Sprod, Michelle Janelsins, Luke Peppone, Jeff Sloan, Karen Basen Engquist, Lee Jones, Diana Buist, Electra D Paskett.   

Abstract

As the number of cancer survivors expands, the need for cancer control and survivorship research becomes increasingly important. The National Cancer Institute (NCI) Cooperative Groups may offer a viable platform to perform such research. Observational, preventive, and behavioral research can often be performed within the cooperative group setting, especially if resources needed for evaluation are fairly simple, if protocols are easily implemented within the typical clinical setting, and if interventions are well standardized. Some protocols are better suited to cooperative groups than are others, and there are advantages and disadvantages to conducting survivorship research within the cooperative group setting. Behavioral researchers currently involved in cooperative groups, as well as program staff within the NCI, can serve as sources of information for those wishing to pursue symptom management and survivorship studies within the clinical trial setting. The structure of the cooperative groups is currently changing, but going forward, survivorship is bound to be a topic of interest and one that perhaps may be more easily addressed using the proposed more centralized structure. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21502540      PMCID: PMC3124556          DOI: 10.1158/1055-9965.EPI-11-0176

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

1.  Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

Authors:  M R Hamre; L L Robison; M E Nesbit; H N Sather; A T Meadows; J A Ortega; G J D'Angio; G D Hammond
Journal:  J Clin Oncol       Date:  1987-11       Impact factor: 44.544

Review 2.  Insomnia in the context of cancer: a review of a neglected problem.

Authors:  J Savard; C M Morin
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

Review 3.  Cardiotoxicity induced by chemotherapy and antibody therapy.

Authors:  Edward T H Yeh
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

4.  Fatigue and proinflammatory cytokine activity in breast cancer survivors.

Authors:  Julienne E Bower; Patricia A Ganz; Najib Aziz; John L Fahey
Journal:  Psychosom Med       Date:  2002 Jul-Aug       Impact factor: 4.312

Review 5.  Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.

Authors:  Carla C P Verstappen; Jan J Heimans; Klaas Hoekman; Tjeerd J Postma
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Cancer-treatment-induced bone loss, part 1.

Authors:  Laura Boehnke Michaud; Susan Goodin
Journal:  Am J Health Syst Pharm       Date:  2006-03-01       Impact factor: 2.637

7.  Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia.

Authors:  J H Rowland; O J Glidewell; R F Sibley; J C Holland; R Tull; A Berman; M L Brecher; M Harris; A S Glicksman; E Forman
Journal:  J Clin Oncol       Date:  1984-12       Impact factor: 44.544

Review 8.  Cancer-treatment-induced bone loss, part 2.

Authors:  Laura Boehnke Michaud; Susan Goodin
Journal:  Am J Health Syst Pharm       Date:  2006-03-15       Impact factor: 2.637

9.  NCCN Task Force Report: Bone Health in Cancer Care.

Authors:  Julie R Gralow; J Sybil Biermann; Azeez Farooki; Monica N Fornier; Robert F Gagel; Rashmi N Kumar; Charles L Shapiro; Andrew Shields; Matthew R Smith; Sandy Srinivas; Catherine H Van Poznak
Journal:  J Natl Compr Canc Netw       Date:  2009-06       Impact factor: 11.908

10.  The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard L Theriault; Robert N Davis; Christina A Meyers
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860

View more
  4 in total

Review 1.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

2.  Strategies to improve success of pediatric cancer cooperative group quality of life studies: a report from the Children's Oncology Group.

Authors:  Puja G Whitlow; Mae Caparas; Patricia Cullen; Christine Trask; Fiona Schulte; Leanne Embry; Rajaram Nagarajan; Donna L Johnston; Lillian Sung
Journal:  Qual Life Res       Date:  2014-11-29       Impact factor: 4.147

3.  Facilitating accrual to cancer control and supportive care trials: the clinical research associate perspective.

Authors:  David Vanhoff; Tanya Hesser; Katherine Patterson Kelly; David Freyer; Susan Stork; Lillian Sung
Journal:  BMC Med Res Methodol       Date:  2013-12-31       Impact factor: 4.615

4.  Patient-reported outcomes and experiences from the perspective of colorectal cancer survivors: meta-synthesis of qualitative studies.

Authors:  Claudia Rutherford; Fabiola Müller; Nasiba Faiz; Madeleine T King; Kate White
Journal:  J Patient Rep Outcomes       Date:  2020-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.